
Voglicare-MG 2 Tablet SR
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglicare-MG 2 Tablet SR
Diabetic patients using the dual-action medication, GlycoDuo-2 SR, should be aware it's prescribed for adult-onset type 2 diabetes. This formulation helps regulate blood glucose. GlycoDuo-2 SR tablets are to be taken orally with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on individual blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications including nephropathy, retinopathy, neuropathy, and limb loss. GlycoDuo-2 SR is only one component of a comprehensive diabetes management plan, encompassing diet, physical activity, and weight management as directed by your healthcare provider. Lifestyle changes are vital to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Recognize these symptoms and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are essential.
Primary Ingredients of Voglicare-MG 2 Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased. A replacement is needed to provide a meaningful response.
Uses of Voglicare-MG 2 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglicare-MG 2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglicare-MG 2 Tablet SR should be administered on an empty stomach.
Common Side effects of Voglicare-MG 2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglicare-MG 2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Voglicare-MG 2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voglicare-MG 2 Tablet SR works:
Voglicare-MG 2 slow-release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Voglicare-MG 2 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Voglicare-MG 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Voglicare-MG 2 Tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Voglicare-MG 2 Tablet SR carries a high likelihood of risk for individuals with kidney impairment and should be strictly avoided. Medical advice is crucial. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglicare-MG 2 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; Voglicare-MG 2 Tablet SR is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Voglicare-MG 2 Tablet SR :
Should you forget a Voglicare-MG 2 Tablet SR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglicare-MG 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
